Joji Suzuki1,2. 1. Brigham and Women's Hospital, Boston, MA. 2. Harvard Medical School, Boston, MA.
Abstract
BACKGROUND AND OBJECTIVES: A feared complication of opioid use disorder (OUD) is intravenous drug use related infective endocarditis (IDU-IE). We report on our experience engaging hospitalized IDU-IE patients to initiate medication-assisted treatment (MAT). METHODS: A retrospective study (n = 29) using descriptive statistics. RESULTS: Overall, 9 (31.0%) successfully initiated buprenorphine maintenance during the hospitalization, and 9 (31.0%) accepted a referral to methadone maintenance following discharge. Eleven (37.9%) declined MAT altogether. DISCUSSION AND CONCLUSIONS: Hospitalizations may represent an important opportunity to engage IDU-IE patients to initiate MAT. SCIENTIFIC SIGNIFICANCE: The study provides preliminary support of engaging hospitalized IDU-IE patients to initiate MAT.
BACKGROUND AND OBJECTIVES: A feared complication of opioid use disorder (OUD) is intravenous drug use related infective endocarditis (IDU-IE). We report on our experience engaging hospitalized IDU-IE patients to initiate medication-assisted treatment (MAT). METHODS: A retrospective study (n = 29) using descriptive statistics. RESULTS: Overall, 9 (31.0%) successfully initiated buprenorphine maintenance during the hospitalization, and 9 (31.0%) accepted a referral to methadone maintenance following discharge. Eleven (37.9%) declined MAT altogether. DISCUSSION AND CONCLUSIONS: Hospitalizations may represent an important opportunity to engage IDU-IE patients to initiate MAT. SCIENTIFIC SIGNIFICANCE: The study provides preliminary support of engaging hospitalized IDU-IE patients to initiate MAT.
Authors: Alysse G Wurcel; Griffin Boll; Deirdre Burke; Rani Khetarpal; Patrick J Warner; Alice M Tang; Kenneth G Warner Journal: Ann Thorac Surg Date: 2019-10-17 Impact factor: 4.330
Authors: Joji Suzuki; Jennifer A Johnson; Mary W Montgomery; Margaret C Hayden; Christin N Price; Daniel A Solomon; Jane M Liebschutz; Jeffrey L Schnipper; Roger D Weiss Journal: J Addict Med Date: 2020 Jul/Aug Impact factor: 3.702
Authors: Mahbub Jamil; Ibrahim Sultan; Thomas G Gleason; Forozan Navid; Michael A Fallert; Matthew S Suffoletto; Arman Kilic Journal: J Thorac Dis Date: 2019-11 Impact factor: 2.895
Authors: Joshua A Barocas; Mam Jarra Gai; Brenda Amuchi; Raagini Jawa; Benjamin P Linas Journal: Drug Alcohol Depend Date: 2020-08-01 Impact factor: 4.852